Literature DB >> 25032534

Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.

Richard Lee Price1, Ennio Antonio Chiocca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25032534      PMCID： PMC4104417          DOI： 10.1227/NEU.0000000000000390

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  103 in total

Review 1.  Gene and viral therapy for glioblastoma: a review of clinical trials and future directions.

Authors:  Ahmed Mohyeldin; Ennio Antonio Chiocca
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

2.  Early-stage progress on glioma vaccines.

Authors:  Vicki Brower
Journal:  J Natl Cancer Inst       Date:  2011-08-31       Impact factor: 13.506

3.  Newcastle disease virus selectively kills human tumor cells.

Authors:  K W Reichard; R M Lorence; C J Cascino; M E Peeples; R J Walter; M B Fernando; H M Reyes; J A Greager
Journal:  J Surg Res       Date:  1992-05       Impact factor: 2.192

4.  The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study.

Authors:  V Papanastassiou; R Rampling; M Fraser; R Petty; D Hadley; J Nicoll; J Harland; R Mabbs; M Brown
Journal:  Gene Ther       Date:  2002-03       Impact factor: 5.250

5.  PIK3CA alterations in primary (de novo) and secondary glioblastomas.

Authors:  Daisuke Kita; Yasuhiro Yonekawa; Michael Weller; Hiroko Ohgaki
Journal:  Acta Neuropathol       Date:  2007-01-18       Impact factor: 17.088

6.  HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival.

Authors:  S Harrow; V Papanastassiou; J Harland; R Mabbs; R Petty; M Fraser; D Hadley; J Patterson; S M Brown; R Rampling
Journal:  Gene Ther       Date:  2004-11       Impact factor: 5.250

7.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

Authors:  S M Freeman; C N Abboud; K A Whartenby; C H Packman; D S Koeplin; F L Moolten; G N Abraham
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

Review 8.  Understanding high grade glioma: molecular mechanism, therapy and comprehensive management.

Authors:  Yongzhi Wang; Tao Jiang
Journal:  Cancer Lett       Date:  2013-01-20       Impact factor: 8.679

9.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

10.  Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma.

Authors:  Zhigang Liu; Xiumei Zhao; Hua Mao; Patricia A Baxter; Yulun Huang; Litian Yu; Lalita Wadhwa; Jack M Su; Adekunle Adesina; Lazlo Perlaky; Mary Hurwitz; Neeraja Idamakanti; Seshidhar Reddy Police; Paul L Hallenbeck; Richard L Hurwitz; Ching C Lau; Murali Chintagumpala; Susan M Blaney; Xiao-Nan Li
Journal:  Neuro Oncol       Date:  2013-05-07       Impact factor: 12.300
View more
  6 in total

1.  In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures.

Authors:  Rachit Shah; Jacob Petersburg; Amit C Gangar; Adrian Fegan; Carston R Wagner; Sidath C Kumarapperuma
Journal:  Mol Pharm       Date:  2016-03-29       Impact factor: 4.939

2.  A Population-Based Study of Treatment and Survival in Older Glioma Patients.

Authors:  Anne S Reiner; Stephanie M Lobaugh; Selin Gonen; Eli L Diamond; Katherine S Panageas
Journal:  JNCI Cancer Spectr       Date:  2022-01-05

3.  Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.

Authors:  Navid Redjal; Clemens Reinshagen; Andrew Le; Brian P Walcott; Erin McDonnell; Jorg Dietrich; Brian V Nahed
Journal:  J Neurooncol       Date:  2016-02-01       Impact factor: 4.130

4.  Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.

Authors:  Xuemei Zhang; Xuejuan Li; Hongchen Hua; Aiping Wang; Wanhui Liu; Youxin Li; Fenghua Fu; Yanan Shi; Kaoxiang Sun
Journal:  Int J Nanomedicine       Date:  2017-08-08

5.  Clinically useful tumor fluorescence greater than 24 hours after 5-aminolevulinic acid administration.

Authors:  Sameah Haider; Travis Matthew Hamilton; Rachel J Hunt; Ian Y Lee; Adam M Robin
Journal:  Surg Neurol Int       Date:  2022-03-25

Review 6.  Arsenic trioxide as a novel anti-glioma drug: a review.

Authors:  Yi Fang; Zhen Zhang
Journal:  Cell Mol Biol Lett       Date:  2020-09-24       Impact factor: 5.787
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.